Search

In Stock

Buy Adakveo (crizanlizumab) Online

DISEASE INDICATIONS: Sickle Cell Disease

MANUFACTURER: Novartis

USAGE: Intravenous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Adakveo, with its active ingredient crizanlizumab, is a prescription medication used in the treatment of a specific medical condition known as sickle cell disease (SCD).

$1,844.95

Clear
Compare

Adakveo, with its active ingredient crizanlizumab, is a prescription medication used in the treatment of a specific medical condition known as sickle cell disease (SCD). Sickle cell disease is a genetic blood disorder characterized by the presence of abnormal hemoglobin, causing red blood cells to become misshapen and break down easily. This can lead to a variety of complications, including severe pain episodes known as vaso-occlusive crises.

Adakveo is a novel therapeutic option designed to reduce the frequency and severity of vaso-occlusive crises in individuals with sickle cell disease. It is classified as a monoclonal antibody, which means it is a specialized protein that targets a specific molecule in the body to achieve its therapeutic effects.

Here are some key aspects of Adakveo (crizanlizumab):

  1. Mechanism of Action: Adakveo works by inhibiting a protein called P-selectin, which plays a crucial role in the adhesion of sickle-shaped red blood cells to the blood vessel walls. By blocking P-selectin, Adakveo helps prevent the clustering of these abnormal cells, reducing the risk of painful vaso-occlusive crises.
  2. Indications: Adakveo is primarily indicated for the prevention of vaso-occlusive crises in individuals with sickle cell disease. It is not a cure for the disease but can help manage its symptoms and complications.
  3. Administration: The medication is typically administered through intravenous (IV) infusion in a healthcare setting. The frequency and dosage will be determined by a healthcare provider based on the patient’s specific needs and medical history.
  4. Clinical Efficacy: Clinical trials have demonstrated that Adakveo can significantly reduce the frequency of vaso-occlusive crises and hospitalizations in individuals with sickle cell disease. It has shown promise in improving the overall quality of life for those living with this condition.
  5. Side Effects: Like any medication, Adakveo may have side effects. Common side effects may include nausea, joint pain, back pain, fever, and infusion-related reactions. It’s essential for patients to discuss potential side effects with their healthcare provider.
  6. Monitoring: Patients taking Adakveo may require regular monitoring by their healthcare team to assess its effectiveness and safety. This may involve blood tests and other assessments.
  7. Precautions: Adakveo is not suitable for everyone, and its use should be carefully considered in consultation with a healthcare provider. It may interact with other medications or medical conditions, so a comprehensive medical history should be provided to the prescribing physician.

Adakveo represents an important advancement in the management of sickle cell disease, offering hope for improved quality of life for individuals affected by this challenging condition. As with any medical treatment, it should be prescribed and administered under the supervision of qualified healthcare professionals.

Package

100 mg/10 ml

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Inrebic (fedratinib) Online

$5,242.36
(0 Reviews)
DISEASE INDICATIONS: Myelofibrosis MANUFACTURER: Impact Biomedicines, Inc. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Inrebic, known by its generic name Fedratinib, is a medication used to treat certain rare bone marrow disorders, specifically myelofibrosis.

Buy Oxbryta (voxelotor) Online

$33,074.12
(0 Reviews)
ISEASE INDICATIONS: Sickle Cell Disease MANUFACTURER: Global Blood Therapeutics, Inc. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Oxbryta, known by its generic name Voxelotor, is a pharmaceutical medication used to treat a rare genetic blood disorder called sickle cell disease (SCD).

Buy Evrenzo (Roxadustat) Online

From $171.42
(0 Reviews)
DISEASE INDICATIONS: Anemia MANUFACTURER: Astellas Pharma Inc. FibroGen USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Pharmaceuticals and Medical Devices Agency (PMDA) Evrenzo, known by its generic name Roxadustat, is a pharmaceutical medication that belongs to a class of drugs called HIF-PH (Hypoxia-Inducible Factor Prolyl Hydroxylase) inhibitors. This innovative medication is primarily used to treat certain types of anemia, particularly those associated with chronic kidney disease (CKD) and inflammation.

Buy Givlaari (givosiran) Online

(0 Reviews)
DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP) MANUFACTURER: Alnylam Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Givlaari, known by its generic name Givosiran, is a pharmaceutical medication used to treat a rare genetic disorder called acute hepatic porphyria (AHP). This innovative medication represents a significant advancement in the management of this condition, which is characterized by recurrent, severe attacks of abdominal pain, neurological symptoms, and potential life-threatening complications.

Buy Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) Online

$24,063.64
(0 Reviews)
DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Andexxa, with its generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used in the field of hematology and coagulation medicine. It is primarily designed to address life-threatening bleeding events or complications associated with the use of certain anticoagulant medications, specifically direct or indirect factor Xa inhibitors.

Buy Ondexxya (andexanet alfa) Online

$16,421.35
(0 Reviews)
DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ondexxya, known by its generic name Andexanet Alfa, is a medication used as a reversal agent for certain anticoagulant medications. It is primarily used in emergency situations when rapid reversal of the anticoagulant effects is necessary, particularly in cases of life-threatening bleeding or when invasive procedures are required.

Buy Accrufer (ferric maltol) Online

(0 Reviews)
DISEASE INDICATIONS: Iron deficiency MANUFACTURER: Shield Therapeutics USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Swissmedic (CH) Accrufer, with the generic name ferric maltol, is a prescription medication used in the treatment of iron deficiency anemia in adults. It is classified as an iron replacement therapy and is designed to help raise and maintain healthy levels of iron in the body.

Back to Top
Product has been added to your cart